|
|
||||||||
Articles |
1
Department of Clinical Chemistry, University Hospital Rotterdam, 3000 CA Rotterdam, The Netherlands.
2
Department of Pulmonology and Critical Care Medicine,
Stanford University Medical Center, Stanford, CA 94305.
3
Institute Gustave-Roussy, Department of Clinical
Chemistry, Villejuif F-94805, France.
4
Medizinische Hochschule Hannover, Institut für
Klinische Chemie I, D-30623 Hannover, Germany.
5
Department of Clinical Chemistry and Hematology,
Hospital Lievensberg, NL 4624 VT Bergen op Zoom, The Netherlands.
a Address correspondence to this author at: Department of Clinical Chemistry, University Hospital Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. Fax 31 10 436 7894; e-mail lindemans{at}ckcl.azr.nl.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
One of the latest newcomers in this field of decentralized point-of-care testing by use of sensor technology is the SenDx 100® blood gas/electrolyte analyzer (SenDx Medical, Inc., Carlsbad, CA).1 This portable tabletop instrument contains a sample introduction stylus, a disposable sensor cassette, a printer, a liquid crystal display touch color screen, and a disposable calibration cartridge. Each combination of calibration cartridge and sensor cassette allows the measurement of 50, 100, or 200 patient samples and at least 100 control samples within a period of 2 weeks. The cartridge contains sensors for pH, PCO2, PO2, sodium, potassium, ionized calcium, and conductivity (as a measure for hematocrit).
The SenDx 100 retains the features of a traditional laboratory bench analyzer but is portable and is intended for use in a near-patient setting. The SenDx 100 permits traditional quality-control procedures, which cover the entire analytical phase of the measurement, including the sensors. Specific lock-out procedures in the resident software preclude use of an improperly functioning sensor cassette or use by unauthorized personnel.
In the present study, four instruments were evaluated at four different clinical institutions with respect to imprecision, inaccuracy, and comparability of patient-sample results with three different routinely used laboratory blood gas/electrolyte analyzers.
| Materials and Methods |
|---|
|
|
|---|
The analyzer measures 13 x 8 x 9 inches and weighs 14 pounds. The sensors are incorporated into a visible sample measurement cassette that uses ~170 µL of blood sample, which is introduced by aspiration. The temperature of the measuring chamber is monitored continuously and regulated at 37.0 °C during calibration and analysis. A self-contained disposable cartridge contains the calibrator/wash reagents and a waste container. In this study, the instrument was ready for analysis continuously and did not need preanalysis calibration. An automatic two-point calibration was scheduled every 4 h. The built-in battery is charged continuously when the analyzer is plugged into an electrical outlet, which allows the instrument to operate on battery power for ~30 analyses or 1 h. Patient data and quality-control results can be downloaded and stored on disk. The built-in printer provides a hard copy of patient results and calibration and quality-control data.
thin-film tonometer
Each testing site was equipped with an IL 237 tonometer
(Instrumentation Laboratory Co.) and supplied with appropriate,
certified gas mixtures.
comparison analyzers
Laboratories A and C used the ABL 505 from Radiometer; laboratory
B used Chiron 288 and 270 (Chiron Diagnostics) as comparison
instruments. Laboratory D used an Instrumentation Laboratory type 1312
blood gas analyzer for blood gases and the Beckman CX3 analyzer
(Beckman Instruments) for electrolytes (on plasma samples). Hematocrit
comparisons were conducted against routinely used automated hematology
analyzers, which were themselves calibrated against the centrifuged
hematocrit.
materials
For imprecision studies, the "three-level" Euro-Trol Gas-ISE
Protein, lot nos. AD1541C, AD2543C, and AD3544C, respectively
(Euro-Trol bv) were used in all participating laboratories. Comparison
instruments were used with the manufacturers' reagents and
calibrators. For tonometry, each laboratory applied two different gas
mixtures, which were analyzed with a relative inaccuracy of <2% for
O2 and CO2 (in practice between 0.1
and 0.2 volume percent absolute) and certified.
whole blood samples
Each testing site analyzed 80100 anaerobically handled,
heparin-treated (3-mL syringe with 7 units/mL dry lithium heparin)
patient samples, selected without conscious bias from those received
routinely in the laboratory. For tonometry, heparin-treated (15
units/mL) whole blood was collected from healthy human volunteers.
protocol
Within-day imprecision.
On each of 3 days, sequential samples
of each Euro-Trol control were analyzed 10 times with one cartridge on
the SenDx 100 and the comparison analyzer in each laboratory. This
procedure was repeated with another calibration cartridge and sensor
cassette of a different lot number. In the four institutions, three
different cartridge/cassette combinations in total were used.
Laboratory B accidentally omitted the comparison analyzer data from the
within-day imprecision study; laboratory D did not provide comparison
analyzer data for electrolyte because they could not use the control
material in their comparison analyzer.
Between-day imprecision.
For 10 days, a Euro-Trol control was
analyzed in duplicate with both the SenDx 100 and the comparison
analyzer in random order.
Tonometry.
Tonometry using fresh, heparin-treated human whole
blood was performed, according to IFCC recommendations on tonometry of
blood (7), on 3 days on both the SenDx 100 and the
corresponding comparison analyzer in each laboratory. For each gas
mixture, the exact partial pressures were calculated daily, with
barometric pressures taken into into consideration. The temperature of
the blood/gas equilibrium chamber was carefully monitored to maintain a
constant tonometer temperature of 37.0 ± 0.1 °C. This
procedure was repeated with a different cassette and calibration
cartridge.
The differences of 10 consecutive measurements with the corresponding target value were calculated and averaged. The overall mean of all averaged differences was then taken as a measure for inaccuracy, either absolute or as a percentage of the target value.
Method comparison.
Each participating laboratory analyzed
80100 anaerobically handled blood samples in split-sample
fashion with the SenDx 100 analyzer and the corresponding comparison
instrument, according to NCCLS guidelines (8).
Patient blood samples collected in heparin-containing syringes were taken at random from those submitted routinely to the laboratory by pneumatic tube or by hand delivery. The samples were remixed by hand immediately and analyzed with the SenDx 100 and the comparison analyzer. The maximum allowable time interval between the two measurements was 3 min. In laboratory D, one-half the sample was transferred to a centrifuge tube, and plasma for electrolyte measurement on the CX3 was prepared by centrifugation. The other half was used for measuring blood gases on the SenDx 100 and the comparison analyzer.
Two different SenDx 100 cassettes were used (4050 samples/cassette), each for at least 5 days. On each operating day, sampling of two Euro-Trol control materials was scheduled to ascertain that both analyzers were within 2 SD of the target value during the whole comparison period.
statistical data analysis
Before statistical analysis, all data were subjected to an outlier
rejection procedure according to the NCCLS EP9-A guideline
(8). All data from different observation days and different
lot numbers were processed together unless indicated. The significance
of differences in the means were tested using the Student
t-test. Patient-sample comparisons were pooled from all four
institutions and analyzed by calculating the slope and intercept from a
regression analysis according to Passing and Bablok (9);
bias and variability of differences were analyzed according to Bland
and Altman (10).
| Results |
|---|
|
|
|---|
Generally, the within-day imprecision of the four instruments and the
respective comparison analyzers showed similar CVs for pH,
PO2,
PCO2, and potassium (Table 1
). Sodium and ionized calcium measurements on the SenDx 100 were
less precise than those of the comparison analyzers. The between-day
imprecision (Table 2
) was better on most comparison instruments for pH,
PCO2, sodium, and ionized calcium,
but was better on the SenDx 100 for
PO2 and potassium. There were no
clinically significant differences (generally <2%) between different
sensor cassettes and reagent cartridges. Table 3
summarizes the averaged data for all control materials in all
four centers. The CV data for within- and between-day imprecision for
electrolytes in laboratory D were obtained separately with a different
sample type and given just for the purpose of comparison with a
different technique (indirect measurement).
|
|
|
inaccuracy studies
The tonometry data for both PO2
and PCO2 are shown in Table 4
. The mean recoveries with the SenDx 100 at ~70 and 142 mmHg
PO2 were 98.5% and 95.2%,
respectively; at ~36 and 72 mmHg
PCO2, the mean recoveries were
103.9% and 100.2%, respectively. The data on the comparison analyzers
were somewhat more favorable. The data from one center were also used
to evaluate the within-run and between-run imprecision with
heparin-treated nondiseased human blood under controlled conditions.
Table 5
shows that the imprecision values for
PCO2 in the treated whole blood were
similar to the values for the Euro-Trol control materials; however, the
imprecision values for PO2 were much
improved, as is expected when whole blood is used instead of an aqueous
solution.
|
|
method comparison
The results of the comparison of the SenDx 100 with the comparison
analyzers, using fresh patient samples are represented in Fig. 1
and Table 6
for all analytes assayed. The data from the four institutions
are presented in one graph, with a different symbol for each
participant. This makes it possible to discern general discrepancies
caused by bias in one specific laboratory.
|
|
For the pH, an average bias of only 0.010 was found, with an insignificant positive trend (slope = 0.984). The PCO2 showed a bias of -0.65 mmHg, which was independent of the partial pressure of CO2. The PO2 had a very small positive slope (0.943), suggesting a slight dependence on the partial pressure of O2. Otherwise there was no significant difference from zero for the average bias of -0.49 mmHg.
With respect to sodium, a statistically significant but otherwise small bias of 0.44 mmol/L was found in the sample comparison study; there was no significant concentration dependency. The comparison for potassium showed no significant bias for all participants taken together; however, a discrepancy was found for the comparison analyzer in one laboratory (D), which gave consistently higher results than the SenDx 100 analyzer. Without these data, a small negative bias probably would have occurred. Again, there was no apparent concentration dependency of the bias. The majority of ionized calcium values were within close limits; therefore, it is difficult to confirm or deny whether the differences between analyzers were concentration-dependent. The average bias is small, 0.015 mmol/L, but statistically significant.
The hematocrit showed a slightly negative slope and an average bias of -0.016 L/L, with an SD of 0.032 L/L.
| Discussion |
|---|
|
|
|---|
This is also applicable to the accuracy measurements. Although the SenDx 100 analyzer demonstrated a larger bias than the respective comparison analyzers, in particular for the PO2, the overall accuracies for PO2 and PCO2 were quite satisfactory in comparison with established performance indicators for these analytes.
Different sensor systems react differently toward various matrices of quality-control materials. Differences in performance between instruments can therefore be judged best from split patient-sample comparisons. With respect to differences between cartridge lots, no significant differences were found for any of the investigated analytes with the exception of ionized calcium, for which the difference in bias between cartridges reached a significant value of 0.05 mmol/L (n = 44). Clinically, this is of little importance. For PO2, the average biases found at 70 and 140 mmHg were of the same magnitude as with the tonometry experiment. The average SD of the individual differences appears rather large (almost 6 mmHg). This implies a CV of ~6% around the average PO2. This is in fact not much larger than the CV of 4.2% for PCO2 in the same experiment. Nevertheless, individual differences of ±25 mmHg are disturbing. The majority of these differences are, however, from one laboratory and therefore cannot be attributed solely to the SenDx analyzer.
In comparison with other point-of-care blood gas/electrolyte analyzers, the SenDx 100 performs equally well (13). The SenDx 100 provides a hematocrit value on the basis of conductivity measurement. Stott et al. (14) have demonstrated that such hematocrit determinations are relatively insensitive to changes in the electrolyte composition of the plasma in comparison with electronic particle-counting devices, which use sample dilution in isotonic saline; however, they are particularly sensitive to changes in plasma protein composition in contrast hematocrits obtained with electronic particle counting or centrifugation.
In conclusion, the SenDx 100 analyzer fulfills most of the requirements for a portable blood gas/electrolyte analyzer: acceptable precision and accuracy, comparability with laboratory bench analyzers, ease of use, and fast results.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
The following articles in journals at HighWire Press have cited this article:
![]() |
G. F. Billman, A. B. Hughes, G. G. Dudell, E. Waldman, L. M. Adcock, D. M. Hall, E. N. Orsini Jr, A. J. Koska, L. J. Van Marter, N. N. Finer, et al. Clinical Performance of an In-Line, ex Vivo Point-of-Care Monitor: A Multicenter Study Clin. Chem., November 1, 2002; 48(11): 2030 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Widness, J. C. Kulhavy, K. J. Johnson, G. A. Cress, I. J. Kromer, M. J. Acarregui, and R. D. Feld Clinical Performance of an In-Line Point-of-Care Monitor in Neonates Pediatrics, September 1, 2000; 106(3): 497 - 504. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |